Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Optimizing Particle Size in Nasal Suspensions

Posted on By

.

17. SOP for Optimizing Particle Size in Nasal Suspensions
html
Copy code




SOP for Optimizing Particle Size in Nasal Suspensions



Standard Operating Procedure for Optimizing Particle Size in Nasal Suspensions

1) Purpose

The purpose of this SOP is to outline the procedure for optimizing the particle size in nasal suspensions to ensure uniform drug delivery and effective therapeutic action.

2) Scope

This SOP applies to all personnel involved in the preparation, optimization, and testing of nasal suspensions at [Company Name].

3) Responsibilities

  • Operators: Responsible for monitoring and optimizing particle size during formulation.
  • QA: Verifies the particle size and ensures that it meets formulation specifications.
See also  SOP for Conducting Internal GMP Audits and Corrective Actions

4) Procedure

4.1 Selection of Equipment

4.1.1 Homogenizer or Milling Equipment

  • Select appropriate equipment (e.g., homogenizer, ball mill) to reduce particle size to the desired range (e.g., 1-10 microns).
  • Ensure that the equipment is calibrated and functioning correctly before use.

4.1.2 Particle Size Analyzer

  • Ensure the particle size analyzer is calibrated to measure the size distribution accurately.

4.2 Particle Size Reduction

4.2.1 Homogenization

  • Add the suspension ingredients into the homogenizer, and adjust the speed and pressure according to formulation guidelines.
  • Run the homogenizer for the required
time to reduce the particle size.

4.2.2 Milling

  • If using a milling process, add the suspension to the ball mill or jet mill and run it at the recommended speed and time.

4.3 Particle Size Analysis

4.3.1 Measurement

  • Take a sample of the nasal suspension and measure the particle size distribution using a laser diffraction particle size analyzer or dynamic light scattering (DLS).
  • Ensure the particle size falls within the desired range specified in the formulation.

4.4 Stability Testing

4.4.1 Stability of Suspension

  • Monitor the suspension stability to ensure the particles remain evenly dispersed and do not aggregate over time.
  • Perform stability tests at regular intervals to check particle size, viscosity, and sedimentation.

4.5 Documentation

  • Document the particle size reduction process, equipment parameters, and results in the batch manufacturing record (BMR).
  • Record the particle size distribution values in the particle size log, including operator initials and QA approval.

5) Abbreviations, if any

  • DLS: Dynamic Light Scattering
  • QA: Quality Assurance
  • BMR: Batch Manufacturing Record

6) Documents, if any

  • Batch Manufacturing Record (BMR)
  • Particle Size Distribution Log

7) References, if any

  • USP 39 – Particle Size Analysis of Suspensions

8) SOP Version

Version 1.0

Annexure

Particle Size Distribution Log Template

Date Formulation Particle Size (µm) Operator Initials QA Approval
DD/MM/YYYY Formulation Name Size Operator Name QA Name
           


See also  SOP for Maintenance of Cleanroom Facilities
Nasal Spray Formulations Tags:Cleaning SOP for nasal spray equipment, Environmental control in nasal spray production, Equipment maintenance for nasal sprays, Formulating isotonic nasal sprays, Microbial stability in nasal formulations, Mixing SOP for nasal formulations, Nasal spray API formulation, Nasal spray batch manufacturing SOP, Nasal spray filling machine operation, Nasal spray formulation process, Nasal spray GMP guidelines, Nasal spray homogenization techniques, Nasal spray manufacturing process, Nasal spray packaging SOP, Nasal spray preservative-free formulation, Nasal spray production SOP, Nasal spray stability studies, Nasal spray sterilization process, Nasal spray viscosity monitoring, Particle size control in nasal sprays, pH adjustment in nasal formulations, Quality control in nasal spray production, Solvent selection for nasal sprays, SOP for nasal spray manufacturing, SOP for nasal spray testing

Post navigation

Previous Post: SOP for Incorporating Anti-Inflammatory Agents in Nasal Sprays
Next Post: SOP for Monitoring Viscosity of Nasal Gels and Suspensions

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version